Skip to content

AESEG - Medicamentos genéricos

Did you know?

A generic and a branded medicine have the same active substance and, therefore, they are interchangeable »

A generic medicine has the same quality, efficacy and safety as the original product »

Generic medicines can reduce the price of an innovator product up to 60% »

Generic medicines cost less because there has been no investment to discover them »

The first generic medicine commercialised in Spain was the AZT or Zidovudina for the treatment of HIV »

The use of generic medicines in the National Public Health departments is increasing »

You differentiate a generic because it has the name of the active substance and the letters EFG on its label »

Who is AESEG

AESEG is the official representative body of the generic and biosimilar pharmaceutical industry in Spain, representing 96% of the Spanish generic market in value. Any pharmaceutical company manufacturing raw materials and pharmaceutical active substances as well as technological development companies that focus activities on generic medicines in Spain can be a member of AESEG.

AESEG was constituted in Barcelona in March 1998 as a nationwide non-profit organisation, aimed to foster awareness and use of generic medicines and to create a real generic medicines culture in the heart of the Spanish society.

AESEG is the main association that represents the generic medicine sector before Public Administrations and professional groups (doctors and pharmacists) to guarantee the correct development of generic medicines within a consistent regulatory and legal framework. One of the foundational aims of AESEG is to establish a strategy to help its members comply with deontological and health regulations.

AESEG has a double aim: to support the recognition of the role of generic medicines as a saving mechanism for the budget of the Spanish Health System and, at the same time, to develop a friendly culture for the generic medicines in Spain.